Tag Archive for: President

Life Science Partner announces the recruitment of Roger Lias, PhD, to Wheeler Bio to advance their expansion as cutting-edge biologics CDMO.

Roger Lias Wheeler Bio

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer to accelerate their growth as an industry leader in biologics development services. With a new state-of-the-art Oklahoma City facility, Wheeler Bio has revolutionized the speed of drug discovery with their novel hub-and-spoke concept and Portable CMC® platform that fast-tracks the pathway to IND.

After a nationwide search campaign, Roger Lias, PhD, former Chief Commercial Officer of Vibalogics, was recruited by Life Science Partner to serve as Wheeler Bio’s President and Chief Operating Officer beginning in September 2022.

Lias’ well-established credibility in the biopharma CDMO industry combined with his entrepreneurial leadership experience made him an absolute fit for growing Wheeler Bio into the global partner of choice for biological companies.”

Tom Callaway, MD, Founder of Life Science Partner

Lias will hit the ground running joining the Wheeler Bio team at the BioProcess International Conference in Boston this month, September 2022. In his new role Lias will be responsible for spearheading strategic business opportunities, alliances and joint ventures and will lead a scalable business operations team keeping Wheeler’s technology development and functions aligned with the corporate strategy as industry demand increases.

Prior to joining Wheeler Bio, Lias served as the Chief Commercial Officer for Vibalogics, a Private Equity-backed CDMO that was acquired by Recipharm AB in February, 2022.  He has an extensive track record of entrepreneurial successes including Stelis Biopharma, Avid Biosciences, Allergan, Eden Pharma, Cytovance and KBI Biopharma.

Lias holds a Bachelor of Science degree in Physiology and Biochemistry from the University of Southampton in the United Kingdom. He earned his PhD from Clare College, University Cambridge.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Pamela Goldberg to lead the Medical Device Innovation Consortium as President and Chief Executive Officer.

Prior to starting her own consulting firm in 2017, Ms. Goldberg served as the CEO of the Massachusetts Technology Collaboration, a public economic development engine designed to foster technological advancements, where she helped launch Massachusetts to national leadership for adoption and interoperability of electronic medical records and collaborated to build the health information exchange connection to the EHR.

She will succeed Bill Murray as CEO, whom Life Science Partner recruited at the organization’s inception, and is well-suited to lead MDIC into its next phase of growth and impact, building on the foundational successes of Mr. Murray and his team.

Pamela Goldberg

“Pamela’s solid entrepreneurial experience synergizing objectives for multiple government and for-profit institutions, combined with her successful leadership experience in digital health advancements, leveraging big data, and advancing healthcare technological innovation, make her uniquely suited to lead this pioneering organization,” said Tom Callaway, MD, Founder and President of Life Science Partner. “We are confident MDIC and the many stakeholders it serves will benefit greatly from her thoughtful leadership in the months and years to come.”

Ms. Goldberg has demonstrated consistent success in working across the boundaries of government, in both non-profit and private industry and with regulatory bodies to drive consensus. Previously, Ms. Goldberg served as director of The Center for Entrepreneurial Leadership at Tufts University, a program she launched to drive innovation for the university. Ms. Goldberg received her BA from Tufts University and her MBA from Stanford University.

The MDIC, through its public-private partnership between government and regulatory agencies, non-profits, and the medical device industry, aims to advance regulatory science and bring innovative technologies to patients. MDIC coordinates the development of methods, tools, and resources used in managing the medical device life cycle to improve patient access to cutting-edge medical technology.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders.

MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

More information is available here.

Life Science Partner recruits Rob Shaw, Former Executive Director of the Georgia Chapter of the Juvenile Diabetes Research Foundation.

Life Science Partner announces the recruitment of Rob Shaw, a not-for-profit healthcare focused executive, to the Georgia Arthritis Foundation. 

The Arthritis Foundation is a nationwide nonprofit organization leading efforts to prevent, control and cure arthritis and related diseases with more than 500,000 volunteers, 46 chapters and 150 community service sites.  The Georgia Arthritis Foundation works to improve the quality of life for children and adults with rheumatic diseases and their families.  The Arthritis Foundation works to improve medical care, provide collective and individual advocacy, stimulate research, and provide education and support for a disease that affects people of all ages.

Shaw is an experienced fundraiser and health advocate.  In Shaw’s most recent role at the Georgia Chapter of the Juvenile Diabetes Research Foundation (JDRF), he successfully led the organization in raising millions of dollars each year for the JDRF program through a wide variety of community fundraising events and a major gifts program.

A native Floridian, Rob moved to the coast of Georgia in 1992 and then relocated to Atlanta in 1994.  Over the past thirteen years, Rob has been actively working with not-for-profits including: Project Open Hand, AIDS Walk Atlanta and the American Heart Association.

“In addition to being a seasoned and successful fundraising executive, Rob exhibits a genuine passion and commitment that is magnet for enthusiastic volunteers and board members,” noted Tom Callaway, MD, founder and president of Life Science Partner.

Rob received his Bachelors degree in Science and Journalism from the University of Florida in Gainesville.

Life Science Partner places sales and marketing veteran to guide U.S.-based operations and commercialization for innovative medical device firm.

Life Science Partner announces the placement of Patrick A. Maley as president, North America for Itamar Medical, Ltd. In this capacity, Maley assumes overall responsibility for U.S.-based operations. He will establish the company’s commercialization strategy; build a sales and marketing team; lead pharmaceutical, medical and other partnering efforts; and represent the company to financial institutions, the medical community and the media.

Israel-based Itamar has developed a technology, the peripheral arterial tone signal or PAT. Among other applications, PAT improves diagnoses of disorders related to arterial health, such as sleep apnea.

“Patrick has a distinguished, decades-long record of bringing novel products to market for both established medical device companies and start-ups,” says Thomas H. Callaway, Life Science Partner’s founder and president. “And his ability to apply creative marketing and reimbursement strategies has yielded commercial results for innovative technologies.”

From re-thinking product distribution channels to building high-performance sales and marketing divisions to negotiating multi-million-dollar global partnerships, Maley’s efforts have repeatedly contributed to steady revenue growth. Maley comes to Itamar from the chief operating officer position at Biowave, where he led organizational development and go-to-market strategy for an innovative pain therapy product.

As vice president of sales and marketing – business development at Matritech, Maley held worldwide commercialization responsibilities for bladder, cervical, prostate, breast and colon cancer products. For Zoll Medical, as vice president of sales and marketing, Maley managed global marketing and North American sales, with profit-and-loss responsibility for a 110-person team. While at Zoll, he re-positioned product lines, re-organized the sales force according to target market, and better integrated sales, marketing and R&D.

Maley also held vice president titles and led global sales and marketing teams at Boston Scientific’s Mansfield Cardiology Division, medical device start-up company ASI, and Alcon Surgical.

Maley earned both a bachelor’s degree in economics and an MBA from the University of California, Riverside.